UCSF Testing Medical Marijuana for Cancer Pain
UCSF researchers are conducting a study to determine if it is safe and effective to use smoked marijuana in combination with opioid pain medications to treat cancer pain.
University of California San Francisco
Give to UCSF
UCSF vascular surgeons develop new technique to repair aortic arch aneurysm
A novel treatment developed by UCSF vascular surgeons has been used in a first-of-its-kind operation to repair a life-threatening aneurysm in the patient's aortic arch, which carries blood from the heart.
Proteomics advance: scientists determine identity, cell locale and quantity of nearly all proteins
UCSF scientists have developed a set of powerful tools that allow researchers to look in unprecedented detail at the full complement of thousands of proteins acting and interacting in a living organism.
Many women can safely extend cervical cancer screening interval to three years
Many women can safely extend their cervical cancer screening interval to three years, according to a new study published in The New England Journal of Medicine.
New Bay Area center will unite local experts in breast cancer research
A new federally funded Bay Area center will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of the disease in some regional counties.
Airline infant safety seat rule could cause more deaths than it prevents, pediatricians say
A proposed Federal Aviation Administration (FAA) regulation that would require infant restraint seats for children under age two would likely lead to more deaths in automobile crashes than the deaths prevented in air crashes
Study raises doubts about ability of bone marrow-derived adult stem cells to differentiate in heart
A study led by UCSF investigators indicates that bone marrow-derived cells from mice that are transplanted into other mice fuse with cells in the animals' heart, brain and liver, and take on their characteristics.
New UCSF-based center will
A new federally funded Center, based at UCSF, will bring together local health experts to investigate possible environmental links to breast cancer and the high incidence of disease in the Bay Area.
HIV's assault on immune system
A UCSF-Gladstone Institute of Virology and Immunology (GIVI) Center for AIDS Research (CFAR) symposium titled, Immunology of HIV Infection will take place October 22 and 23, 2003.
Progress reported on diabetes, aging and childhood disease research
Top California scientists will report progress this week on studies of Alzheimer's Disease and other diseases of aging, as well as efforts to extend lifespan, develop cures for diabetes and improve diagnosis and treatment of childhood neurological disorders.
UCSF arthritis and joint replacement center will deliver comprehensive care
UCSF has opened a new Arthritis and Joint Replacement Center -- a joint effort between the departments of rheumatology and orthopedic surgery.
Scientists switch components in cell circuits: possible new technology, therapy
By tinkering with a few of the parts in a vital signaling circuit found in human cells, UCSF scientists have demonstrated the possibility of an entirely new technology: developing new devices or therapies by mixing and matching sub-cellular signaling components.
Combining osteoporosis drugs produces no added benefit
Combining two types of drugs prescribed for osteoporosis does not produce a synergistic benefit in treating the disease, according to a study headed by a UCSF researcher.
Researchers now on road to isolating skin stem cells
Researchers at the San Francisco VA Medical Center (SFVAMC) have taken the first major step toward isolating adult stem cells from mouse skin, having developed a test that confirms the presence and number of stem cells in a given amount of tissue.
UCSF begins study testing antiviral drug tenofovir to prevent HIV infection
UCSF researchers have been funded by the National Institutes of Health to study the antiretroviral drug tenofovir as a potential pre-exposure prophylaxis in Cambodia among high-risk, HIV-uninfected women.